Fig. 8From: Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-β1 siRNA for improving spinal tuberculosis therapyEffects of TGF-β1 knockdown measured by (A) qRT-PCR and (B) Western blot. siTGF-β1, siRNA targeting TGF-β1 mRNA; HRZ, control group of HRZ nanoliposomes; siNC, non-coding siRNA control group; Control, PBS group. *P < 0.05; **P < 0.01Back to article page